Back
Akero Therapeutics Vs. Apogee Enterprises Industry Stock Comparison
Buy
75
AKRO
Akero Therapeutics
Last Price:
23.45
Seasonality Move:
38.97%
Buy
61
APOG
Apogee Enterprises
Last Price:
63.05
Seasonality Move:
0.92%
Buy
75
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $23.46. The Score for AKRO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Apogee Enterprises (APOG)
is a Buy
Is Apogee Enterprises a Buy, Sell or Hold?
- The current Apogee Enterprises [APOG] share price is $63.06. The Score for APOG is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- APOG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $23.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $63.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APOG is experiencing slight selling pressure.
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.7 | Buy |
Relative Strength Index (14 RSI): | 57.52 | Buy |
Chaikin Money Flow: | 2733533 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.57 - 23.83) | Buy |
Bollinger Bands (100): | (19.6 - 25.96) | Buy |
APOG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 52.89 | Buy |
Chaikin Money Flow: | -136947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60.7 - 64.72) | Buy |
Bollinger Bands (100): | (56.24 - 63.86) | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.04 | Buy |
20-day SMA: | 22.45 | Buy |
50-day SMA: | 21.05 | Buy |
200-day SMA: | 23.46 | Buy |
8-day EMA: | 23.21 | Buy |
20-day EMA: | 22.53 | Buy |
50-day EMA: | 22.01 | Buy |
200-day EMA: | 25.3 | Sell |
APOG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.18 | Buy |
20-day SMA: | 61.94 | Buy |
50-day SMA: | 63.23 | Sell |
200-day SMA: | 54.21 | Buy |
8-day EMA: | 61.73 | Buy |
20-day EMA: | 62.13 | Buy |
50-day EMA: | 62.04 | Buy |
200-day EMA: | 56.06 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.83 per share, and a decrease next year of $0.65 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.67 per share, and an increase next year of $0.11 per share.
Akero Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apogee Enterprises Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |